| TBXA2R |
TBXA2R: Thromboxane A2 receptor |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
1.132 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
1.132 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
1.132 |
Evidence |
|
| HCK |
IPI00029769 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
| DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
MAPK15 |
IPI00395861 |
1.132 |
Evidence |
|
| PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
1.132 |
Evidence |
|
| HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
1.132 |
Evidence |
|
| BMX |
IPI00514142 |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
1.132 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
| AHR |
AHR: Aryl hydrocarbon receptor precursor |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
1.132 |
Evidence |
|
| IFNG |
IFNG: Interferon gamma precursor |
IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
1.132 |
Evidence |
|
| TFAP4 |
TFAP4: Transcription factor AP-4 |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.132 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
1.132 |
Evidence |
|
| KCNH2 |
KCNH2, ERG, ERG1, HERG, HERG1: Potassium voltage-gated channel subfamily H membe |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
1.132 |
Evidence |
|
| TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
EDA |
IPI00023765 |
1.132 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
1.132 |
Evidence |
|
| KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
SERPINA3 |
IPI00550991 |
1.132 |
Evidence |
|
| EDA |
IPI00023765 |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
1.132 |
Evidence |
|
| ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
HES6 |
HES6: Transcription cofactor HES-6 |
1.132 |
Evidence |
|
| TNFSF12 |
TNFSF13, APRIL, UNQ383/PRO715, TALL2, ZTNF2: Tumor necrosis factor ligand superf |
NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
1.132 |
Evidence |
|
| FASLG |
FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
1.132 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
1.132 |
Evidence |
|
| CD40LG |
CD40LG, CD40L, TNFSF5, TRAP: CD40 ligand |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
1.132 |
Evidence |
|
| AGT |
AGT, SERPINA8: Angiotensinogen precursor |
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
1.132 |
Evidence |
|
| GNAS |
GNAS, GNAS1, GSP: Guanine nucleotide-binding protein G(s) subunit alpha isoforms |
TSHR |
IPI00386365 |
1.132 |
Evidence |
|